Skip to content

Research for the clinical application of external counterpulsation in sleep disorders and the mechanism of functional imaging of nervous system

Using external counterpulsation technique to improve the anti-fatigue ability and its mechanism of brain functional imaging for warfighters

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033645
Enrollment
Unknown
Registered
2020-06-07
Start date
2020-06-15
Completion date
Unknown
Last updated
2020-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep disorders

Interventions

sleep disorder and nervous system development disorder group:External counterpulsation
Health control group:External counterpulsation

Sponsors

Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 25-45 years old; 2. The subjects voluntarily participated in the study and signed the informed consent form by themselves or their legal guardian; 3. The patients with sleep disorder and nervous system development disorder were definitely diagnosed by clinical scale; 4. Normal hearing; 5. Normal vision; 6. IQ > 80; 7. Han nationality; 8. Be able to concentrate; 9. Normal activities of left and right hands; 10. Visual Auditory scale: over 90% familiarity. Other clinical cases were recorded normally.

Exclusion criteria

Exclusion criteria: 1. There are other neurodevelopmental disorders: Intelligence disorders, attention deficit / hyperactivity disorders, communication disorders, specific learning disorders, motor disorders, tic disorders and other types; 2. The following conditions (including but not limited to): neurological and physiological disorders, prenatal, perinatal and postnatal abnormalities, chromosomal diseases and metabolic diseases; Contraindications of treadmill exercise test: according to the guidelines of ACC / AHA ECG exercise test (treadmill exercise test) in 2009; Severe valvular disease, including moderate to severe aortic insufficiency, severe aortic stenosis, severe mitral stenosis and insufficiency; Aortic dissection aneurysm; Severe pulmonary hypertension (mean pulmonary artery pressure > 50mmhg); All kinds of bleeding diseases or bleeding tendency, or anticoagulant, INR > 2.0; Congenital heart disease and hypertrophic cardiomyopathy; Active phlebitis and lower extremity deep vein thrombosis; Severe atherosclerotic obliteration of lower extremity There were infection foci in the limbs; Uncontrolled hypertension (> 180 / 110mmhg); Uncontrolled tachyarrhythmias include frequent ventricular premature beats and ventricular tachycardia. However, patients with AF still benefit; Severe left heart failure (NYHA grade III-IV, ejection fraction = 40%); Pregnancy patients; Failing to sign the informed consent; 3. Previous sufferings: craniocerebral trauma, disturbance of consciousness, epilepsy, more serious cerebral ischemia or cerebral hemorrhage; 4. The subjects had a history of alcohol, drug or mental illness; 5. The subject has participated in any other clinical study within 3 months before joining the clinical study; 6. The researcher believes that there are other circumstances that the subjects are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
MRI imaging;clinical sleep assessment scale;clinical fatigue assessment scale;EEG;ECG;blood pressure;blood oxygen saturation;respiratory;

Countries

China

Contacts

Public ContactShijun Li

Chinese PLA General Hospital

shijunli07@yeah.net+86 13366025298

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026